PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson’s disease rat model

DJ-1 has recently been shown to be responsible for onset of familial Parkinson's disease (PD), PARK7. DJ-1 has been shown to play roles in transcriptional regulation and anti-oxidative stress, and loss of its function is thought to trigger onset of PD. In this study, a recombinant DJ-1 protein was administrated into the brain of PD model rats that had been injected to 6-hydroxydopamine (6-OHDA) in the left substantia nigra. PD phenotypes, including dopaminergic neuron death in the substantia nigra, decrease in dopamine, and dopamine transporter levels in the striatum, and motor abnormality, were dramatically improved by wild-type DJ-1 but not L166P DJ-1, a mutant form of DJ-1 found in PD patients. Furthermore, production of reactive oxygen species and cell death induced by 6-OHDA in SH-SY5Y cells and mesencephalic neurons were inhibited by addition of the recombinant DJ-1. These findings suggest that DJ-1 is a therapeutic target for PD.

[1]  T. Taira,et al.  DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. , 1997, Biochemical and biophysical research communications.

[2]  Xin Zhao,et al.  Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[4]  J. Noth,et al.  DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease , 2004, Neurology.

[5]  T. Niki,et al.  DJ-1 interacts with HIPK1 and affects H2O2-induced cell death , 2006, Free radical research.

[6]  Steven P Gygi,et al.  The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. , 2005, Human molecular genetics.

[7]  Jean-Charles Sanchez,et al.  PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. , 2005, Clinical chemistry.

[8]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  P. Calabresi,et al.  Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 , 2005, Neuron.

[10]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[11]  Y. Kitamura,et al.  Disease model: Parkinson's disease. , 2003, Trends in molecular medicine.

[12]  G. Petsko,et al.  The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  E. Masliah,et al.  Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. , 2006, Biochemical and biophysical research communications.

[14]  A. Abeliovich,et al.  DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation , 2004, PLoS biology.

[15]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[16]  Thomas Floss,et al.  Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism , 2004, PLoS biology.

[17]  T. Niki,et al.  DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. , 2003, Molecular cancer research : MCR.

[18]  C. Haass,et al.  Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1* , 2004, Journal of Biological Chemistry.

[19]  K. Yoshimoto,et al.  Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. , 1996, Alcoholism, clinical and experimental research.

[20]  S. Przedborski,et al.  Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Mark A. Wilson,et al.  The oxidation state of DJ-1 regulates its chaperone activity toward α-synuclein , 2006 .

[22]  P. Seth,et al.  Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells , 2004, Neurobiology of Disease.

[23]  P. Bramanti,et al.  Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease , 2006, Neurobiology of Disease.

[24]  Hiroyoshi Ariga,et al.  DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor* , 2001, The Journal of Biological Chemistry.

[25]  Li Zhang,et al.  A missense mutation (L166P) in DJ‐1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo‐oligomerization , 2003, Journal of neurochemistry.

[26]  K. Takata,et al.  Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats. , 2005, Journal of pharmacological sciences.

[27]  Tiffany Mathews,et al.  Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice* , 2005, Journal of Biological Chemistry.

[28]  Keith D Wilkinson,et al.  Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function* , 2004, Journal of Biological Chemistry.

[29]  P. Lockhart,et al.  Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. , 2005, Brain research. Molecular brain research.

[30]  P. Ragonese,et al.  DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.

[31]  Hiroyoshi Ariga,et al.  Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein. , 2005, International journal of oncology.

[32]  David W. Miller,et al.  Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. , 2005, Brain research. Molecular brain research.

[33]  Y. Kitamura,et al.  Mechanism of resistance to NO‐induced neurotoxicity in cultured rat dopaminergic neurons , 1996, Journal of neuroscience research.

[34]  Jos Prickaerts,et al.  Modeling Parkinson's Disease in Rats: An Evaluation of 6-OHDA Lesions of the Nigrostriatal Pathway , 2002, Experimental Neurology.

[35]  David S. Park,et al.  Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Niki,et al.  DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. , 2005, International journal of oncology.

[37]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[38]  P. Heutink,et al.  The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. , 2003, Human molecular genetics.

[39]  T. Oury,et al.  Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains* , 2005, Journal of Biological Chemistry.

[40]  T. Niki,et al.  The Crystal Structure of DJ-1, a Protein Related to Male Fertility and Parkinson's Disease* , 2003, Journal of Biological Chemistry.

[41]  T. Taira,et al.  Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[43]  T. Iwatsubo,et al.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Y. Kitamura,et al.  Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. , 1998, Molecular pharmacology.

[45]  H. Ariga,et al.  Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. , 2003, Biochemical and biophysical research communications.

[46]  T. Niki,et al.  DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.

[47]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[48]  K. Takata,et al.  High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity , 2004 .

[49]  Hiroyoshi Ariga,et al.  Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress , 2005, Free radical research.

[50]  H. Ariga,et al.  Expression and cellular localization of contraception-associated protein. , 2000, Journal of andrology.

[51]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[52]  T. Niki,et al.  Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities , 2006, Cell Death and Differentiation.

[53]  Liang Tong,et al.  Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease* , 2003, Journal of Biological Chemistry.

[54]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[55]  K. Takata,et al.  Serofendic acid prevents 6‐hydroxydopamine‐induced nigral neurodegeneration and drug‐induced rotational asymmetry in hemi‐parkinsonian rats , 2005, Journal of neurochemistry.

[56]  T. Niki,et al.  Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.

[57]  Thomas Meitinger,et al.  Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.

[58]  Rina Bandopadhyay,et al.  The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. , 2004, Brain : a journal of neurology.

[59]  L. Paraoan,et al.  Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies , 2005, Neurobiology of Disease.

[60]  David W. Miller,et al.  L166P Mutant DJ-1, Causative for Recessive Parkinson's Disease, Is Degraded through the Ubiquitin-Proteasome System* , 2003, Journal of Biological Chemistry.

[61]  Vincenzo Bonifati,et al.  Early‐onset Parkinson's disease caused by a compound heterozygous DJ‐1 mutation , 2003, Annals of neurology.

[62]  H. Lipp,et al.  Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[63]  Reidun Torp,et al.  Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. , 2005, Human molecular genetics.

[64]  M. Cameron Sullards,et al.  Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.

[65]  M. Mintz,et al.  Behavioral and Anatomical Effects of Long-Term l-Dihydroxyphenylalanine (L-DOPA) Administration in Rats with Unilateral Lesions of the Nigrostriatal System , 2002, Experimental Neurology.

[66]  Tomoya Kinumi,et al.  Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. , 2004, Biochemical and biophysical research communications.

[67]  David E. Misek,et al.  Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.